746 related articles for article (PubMed ID: 18332614)
1. Increased platelet cholesterol and decreased percentage volume of platelets as a secondary risk factor for coronary artery disease.
Ravindran R; Krishnan LK
Pathophysiol Haemost Thromb; 2007; 36(1):45-51. PubMed ID: 18332614
[TBL] [Abstract][Full Text] [Related]
2. Plasma HDL-cholesterol has an effect on nitric oxide production and arachidonic acid metabolism in the platelet membranes of coronary heart disease patients without LDL-hypercholesterolemia.
Tretjakovs P; Kalnins U; Dabina I; Dinne I; Erglis A; Kumsars I; Jurka A
Med Sci Monit; 2000; 6(3):507-11. PubMed ID: 11208362
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for coronary artery disease in patients with elevated high-density lipoprotein cholesterol.
DeFaria Yeh D; Freeman MW; Meigs JB; Grant RW
Am J Cardiol; 2007 Jan; 99(1):1-4. PubMed ID: 17196452
[TBL] [Abstract][Full Text] [Related]
4. Comparison of cardiovascular risk and lipid profiles in patients undergoing aortic valve surgery versus those undergoing coronary artery bypass grafting.
Novaro GM; Pearce GL; Sprecher DL; Griffin BP
J Heart Valve Dis; 2001 Jan; 10(1):19-24. PubMed ID: 11206763
[TBL] [Abstract][Full Text] [Related]
5. Abnormalities of cholesterol-phospholipid composition in platelets and low-density lipoproteins of human hyperbetalipoproteinemia.
Shattil SJ; Bennett JS; Colman RW; Cooper RA
J Lab Clin Med; 1977 Feb; 89(2):341-53. PubMed ID: 188956
[TBL] [Abstract][Full Text] [Related]
6. Comparison of platelet fibronectin, ADP-induced platelet aggregation and serum total nitric oxide (NOx) levels in angiographically determined coronary artery disease.
Ekmekçi H; Işler I; Sönmez H; Gürel C; Ciftçi O; Ulutin T; Kökoğlu E; Domaniç N; Dirican A
Thromb Res; 2006; 117(3):249-54. PubMed ID: 16378831
[TBL] [Abstract][Full Text] [Related]
7. Increased platelet glycoprotein V levels in patients with coronary and peripheral atherosclerosis--the influence of aspirin and cigarette smoking.
Blann AD; Lanza F; Galajda P; Gurney D; Moog S; Cazenave JP; Lip GY
Thromb Haemost; 2001 Sep; 86(3):777-83. PubMed ID: 11583307
[TBL] [Abstract][Full Text] [Related]
8. Reduced blood platelet sensitivity to aspirin in coronary artery disease: are dyslipidaemia and inflammatory states possible factors predisposing to sub-optimal platelet response to aspirin?
Markuszewski L; Rosiak M; Golanski J; Rysz J; Spychalska M; Watala C
Basic Clin Pharmacol Toxicol; 2006 May; 98(5):503-9. PubMed ID: 16635110
[TBL] [Abstract][Full Text] [Related]
9. [The effect of smoking on mean platelet volume and lipid profile in young male subjects].
Arslan E; Yakar T; Yavaşoğlu I
Anadolu Kardiyol Derg; 2008 Dec; 8(6):422-5. PubMed ID: 19103537
[TBL] [Abstract][Full Text] [Related]
10. Effect of atorvastatin upon platelet activation in hypercholesterolemia, evaluated by flow cytometry.
Labiós M; Martínez M; Gabriel F; Guiral V; Martínez E; Aznar J
Thromb Res; 2005; 115(4):263-70. PubMed ID: 15668185
[TBL] [Abstract][Full Text] [Related]
11. Preliminary study showing the relationship between platelet fibronectin, sialic acid, and ADP-induced aggregation levels in coronary heart disease.
Bütün II; Ekmekçi H; Sönmez H; Gürel C; Ciftçi O; Ulutin T; Kökoğlu E; Domaniç N; Dirican A
Clin Appl Thromb Hemost; 2007 Jul; 13(3):308-12. PubMed ID: 17636193
[TBL] [Abstract][Full Text] [Related]
12. Effects of cod liver oil on lipids and platelets in males and females.
Hansen JB; Berge LN; Svensson B; Lyngmo V; Nordøy A
Eur J Clin Nutr; 1993 Feb; 47(2):123-31. PubMed ID: 8436090
[TBL] [Abstract][Full Text] [Related]
13. Changes in the hemostatic system and compensatory responses during alimentary hyperlipidemia.
Lucio FJ; Puyol MR; Marques LD; Escribano CG; Duarte AM
Biomed Biochim Acta; 1991; 50(7):893-9. PubMed ID: 1759968
[TBL] [Abstract][Full Text] [Related]
14. Plasma triglycerides and type III hyperlipidemia are independently associated with premature familial coronary artery disease.
Hopkins PN; Wu LL; Hunt SC; Brinton EA
J Am Coll Cardiol; 2005 Apr; 45(7):1003-12. PubMed ID: 15808755
[TBL] [Abstract][Full Text] [Related]
15. Thromboxane biosynthesis in platelets of diabetic and coronary artery diseased patients.
Butkus A; Shirey EK; Schumacher OP
Artery; 1982; 11(3):238-51. PubMed ID: 7184495
[TBL] [Abstract][Full Text] [Related]
16. [Effect of hyperlipoproteinemia on blood fibrinolytic activity and thrombocyte aggregation].
Kostić N; Secen S
Med Pregl; 2000; 53(3-4):180-3. PubMed ID: 10965685
[TBL] [Abstract][Full Text] [Related]
17. Evidence that non-lipid cardiovascular risk factors are associated with high prevalence of coronary artery disease in patients with heterozygous familial hypercholesterolemia or familial combined hyperlipidemia.
Skoumas I; Masoura C; Pitsavos C; Tousoulis D; Papadimitriou L; Aznaouridis K; Chrysohoou C; Giotsas N; Toutouza M; Tentolouris C; Antoniades C; Stefanadis C
Int J Cardiol; 2007 Oct; 121(2):178-83. PubMed ID: 17188767
[TBL] [Abstract][Full Text] [Related]
18. Microcytic thrombocytosis, small megakaryocytes, platelet lipids and hyperreactivity to collagen, lymphocytopenia, eosinophilia, and low blood volume in genetically hyperlipidemic rabbits.
Ebbe S; Dalal K; Forte T; Tablin F
Exp Hematol; 1992 May; 20(4):486-93. PubMed ID: 1568466
[TBL] [Abstract][Full Text] [Related]
19. Enhanced release of sphingosine-1-phosphate from hypercholesterolemic platelets: role in development of hypercholesterolemic atherosclerosis.
Son DJ; Lee HW; Shin HW; Lee JJ; Yoo HS; Kim TJ; Yun YP; Hong JT
Prostaglandins Leukot Essent Fatty Acids; 2008 Jun; 78(6):383-90. PubMed ID: 18571912
[TBL] [Abstract][Full Text] [Related]
20. No effect of lipid lowering on platelet activity in patients with coronary artery disease and type 2 diabetes or impaired glucose tolerance.
Malmström RE; Settergren M; Böhm F; Pernow J; Hjemdahl P
Thromb Haemost; 2009 Jan; 101(1):157-64. PubMed ID: 19132203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
